Pap therapy reduces hospitalizations by 31% and er visits by 23% for people with obstructive sleep apnea and comorbid insomnia

San diego, june 10, 2024 (globe newswire) -- in collaboration with leading medical researchers from around the world, resmed (nyse: rmd, asx: rmd) presented 13 new clinical studies at sleep 2024, the annual joint meeting of the american academy of sleep medicine and the sleep research society. held in houston, the event brought together scientific and medical experts focused on sleep health.
RMD Ratings Summary
RMD Quant Ranking